Publications 2025

Bergo KK, Nordén ES, Bendiksen BA, Espe EKS, McGinley G, Hauge-Iversen IM, Hussain RI, Leh S, Marti HP, Zhang L, Sjaastad I, Cataliotti A (2025)
Sacubitril/valsartan preserves kidney function in rats with cardiorenal syndrome after myocardial infarction
20 (10), e0335214
DOI 10.1371/journal.pone.0335214, PubMed 41134841

Parvan R, Becker V, Hosseinpour M, Moradi Y, Louch WE, Cataliotti A, Devaux Y, Frisk M, Silva GJJ, AtheroNET COST Action CA21153 (2025)
Prognostic and predictive microRNA panels for heart failure patients with reduced or preserved ejection fraction: a meta-analysis of Kaplan-Meier-based individual patient data
23 (1), 409
DOI 10.1186/s12916-025-04238-0, PubMed 40624658

Parvan R, Rolim N, Gevaert AB, Cataliotti A, van Craenenbroeck EM, Adams V, Wisløff U, Silva GJJ, OptimEx Study Group (2025)
Multi-microRNA diagnostic panel for heart failure with preserved ejection fraction in preclinical and clinical settings
12 (4), 3028-3041
DOI 10.1002/ehf2.15324, PubMed 40457688

Publications 2024

Nordén ES, Bendiksen BA, Bergo KK, Espe EKS, McGinley G, Hasic A, Hauge-Iversen IM, Ugland HK, Shen X, Frisk M, Mabotuwana NS, Louch WE, Hussain RI, Zhang L, Sjaastad I, Cataliotti A, Christensen G (2024)
Sacubitril/valsartan preserves regional cardiac function following myocardial infarction in rats
12 (2), 1304-1315
DOI 10.1002/ehf2.15145, PubMed 39696842

Publications 2023

Andresen H, Pérez-Ternero C, Robinson J, Dickey DM, Hobbs AJ, Potter LR, Levy FO, Cataliotti A, Moltzau LR (2023)
Novel enhancers of guanylyl cyclase-A activity acting via allosteric modulation
180 (24), 3254-3270
DOI 10.1111/bph.16203, PubMed 37522273

Espino-Gonzalez E, Tickle PG, Altara R, Gallagher H, Cheng CW, Engman V, Wood N, Justo da Silva GJ, Scalabrin M, Yu X, Zhong Z, Colman MA, Yuldasheva NY, Booz GW, Adams V, Pereira MG, Cataliotti A, Roberts LD, Egginton S, Bowen TS (2023)
Caloric Restriction Rejuvenates Skeletal Muscle Growth in Heart Failure With Preserved Ejection Fraction
9 (2), 223-240
DOI 10.1016/j.jacbts.2023.09.014, PubMed 38510717

Pioppi L, Parvan R, Samrend A, Silva GJJ, Paolantoni M, Sassi P, Cataliotti A (2023)
Vibrational spectroscopy identifies myocardial chemical modifications in heart failure with preserved ejection fraction
21 (1), 617
DOI 10.1186/s12967-023-04465-0, PubMed 37697391

Pioppi L, Tombolesi N, Parvan R, da Silva GJJ, Altara R, Paolantoni M, Morresi A, Sassi P, Cataliotti A (2023)
FTIR Analysis of Renal Tissue for the Assessment of Hypertensive Organ Damage and proANP_31-67 Treatment
24 (6)
DOI 10.3390/ijms24065196, PubMed 36982271

Publications 2022

Parvan R, Hosseinpour M, Moradi Y, Devaux Y, Cataliotti A, da Silva GJJ (2022)
Diagnostic performance of microRNAs in the detection of heart failure with reduced or preserved ejection fraction: a systematic review and meta-analysis
24 (12), 2212-2225
DOI 10.1002/ejhf.2700, PubMed 36161443

Tombolesi N, Altara R, da Silva GJJ, Tannous C, Zouein FA, Stensløkken KO, Morresi A, Paolantoni M, Booz GW, Cataliotti A, Sassi P (2022)
Early cardiac-chamber-specific fingerprints in heart failure with preserved ejection fraction detected by FTIR and Raman spectroscopic techniques
12 (1), 3440
DOI 10.1038/s41598-022-07390-2, PubMed 35236899

Publications 2021

da Silva GJJ, Altara R, Booz GW, Cataliotti A (2021)
Atrial Natriuretic Peptide_31-67: A Novel Therapeutic Factor for Cardiovascular Diseases
12, 691407
DOI 10.3389/fphys.2021.691407, PubMed 34305645

Frisk M, Le C, Shen X, Røe ÅT, Hou Y, Manfra O, Silva GJJ, van Hout I, Norden ES, Aronsen JM, Laasmaa M, Espe EKS, Zouein FA, Lambert RR, Dahl CP, Sjaastad I, Lunde IG, Coffey S, Cataliotti A, Gullestad L, Tønnessen T, Jones PP, Altara R, Louch WE (2021)
Etiology-Dependent Impairment of Diastolic Cardiomyocyte Calcium Homeostasis in Heart Failure With Preserved Ejection Fraction
77 (4), 405-419
DOI 10.1016/j.jacc.2020.11.044, PubMed 33509397

Kaplan A, Altara R, Manca M, Gunes HM, Cataliotti A, Booz GW, Zouein FA (2021)
Distorted assessment of left atrial size by echocardiography in patients with increased aortic root diameter
Egypt. Heart J., 73 (1), 55
DOI 10.1186/s43044-021-00177-2

Nordén ES, Bendiksen BA, Andresen H, Bergo KK, Espe EK, Hasic A, Hauge-Iversen IM, Veras I, Hussain RI, Sjaastad I, Christensen G, Cataliotti A (2021)
Sacubitril/valsartan ameliorates cardiac hypertrophy and preserves diastolic function in cardiac pressure overload
8 (2), 918-927
DOI 10.1002/ehf2.13177, PubMed 33497525

Publications 2020

Altara R, da Silva GJJ, Frisk M, Spelta F, Zouein FA, Louch WE, Booz GW, Cataliotti A (2020)
Cardioprotective Effects of the Novel Compound Vastiras in a Preclinical Model of End-Organ Damage
75 (5), 1195-1204
DOI 10.1161/HYPERTENSIONAHA.120.14704, PubMed 32200677

Bergo KK, Larstorp AC, Hoffmann P, Hjørnholm U, Cataliotti A, Høieggen A, Rostrup M, Fadl Elmula FEM (2020)
Renal sympathetic denervation lowers systemic vascular resistance in true treatment-resistant hypertension
30 (1), 31-40
DOI 10.1080/08037051.2020.1789446, PubMed 32633141

Publications 2019

Røe ÅT, Ruud M, Espe EK, Manfra O, Longobardi S, Aronsen JM, Nordén ES, Husebye T, Kolstad TRS, Cataliotti A, Christensen G, Sejersted OM, Niederer SA, Andersen GØ, Sjaastad I, Louch WE (2019)
Regional diastolic dysfunction in post-infarction heart failure: role of local mechanical load and SERCA expression
115 (4), 752-764
DOI 10.1093/cvr/cvy257, PubMed 30351410

Publications 2018

Altara R, Ghali R, Mallat Z, Cataliotti A, Booz GW, Zouein FA (2018)
Conflicting vascular and metabolic impact of the IL-33/sST2 axis
114 (12), 1578-1594
DOI 10.1093/cvr/cvy166, PubMed 29982301

Altara R, Zouein FA, Brandão RD, Bajestani SN, Cataliotti A, Booz GW (2018)
In Silico Analysis of Differential Gene Expression in Three Common Rat Models of Diastolic Dysfunction
5, 11
DOI 10.3389/fcvm.2018.00011, PubMed 29556499

Ghali R, Altara R, Louch WE, Cataliotti A, Mallat Z, Kaplan A, Zouein FA, Booz GW (2018)
IL-33 (Interleukin 33)/sST2 Axis in Hypertension and Heart Failure
72 (4), 818-828
DOI 10.1161/HYPERTENSIONAHA.118.11157, PubMed 30354724

Kolstad TR, van den Brink J, MacQuaide N, Lunde PK, Frisk M, Aronsen JM, Norden ES, Cataliotti A, Sjaastad I, Sejersted OM, Edwards AG, Lines GT, Louch WE (2018)
Ryanodine receptor dispersion disrupts Ca²⁺ release in failing cardiac myocytes
7
DOI 10.7554/eLife.39427, PubMed 30375974

Publications 2017

Altara R, Giordano M, Norden ES, Cataliotti A, Kurdi M, Bajestani SN, Booz GW (2017)
Targeting Obesity and Diabetes to Treat Heart Failure with Preserved ejection Fraction
Front. Endocrinol., 8, 160
DOI 10.3389/fendo.2017.00160

Giordano M, Ciarambino T, Castellino P, Malatino L, Cataliotti A, Rinaldi L, Paolisso G, Adinolfi LE (2017)
Seasonal variations of hyponatremia in the emergency department: Age-related changes
Am. J. Emerg. Med., 35 (5), 749-752
DOI 10.1016/j.ajem.2017.01.018

Holditch SJ, Schreiber CA, Harris PC, LaRusso NF, Ramirez-Alvarado M, Cataliotti A, Torres VE, Ikeda Y (2017)
B-type natriuretic peptide overexpression ameliorates hepatorenal fibrocystic disease in a rat model of polycystic kidney disease
Kidney Int., 92 (3), 657-668
DOI 10.1016/j.kint.2017.02.017

Todd Milne G, on behalf of the Ironwood team, Sandner P, Lincoln KA, Harrison PC, Chen H, Wang H, Clifford H, Qian HS, Wong D, Sarko C, Fryer R, Richman J, Reinhart GA, Boustany CM, Pullen SS, Andresen H, Moltzau LR, Cataliotti A, Levy FO, Lukowski R, Frankenreiter S, Friebe A, Calamaras T, Baumgartner R et al. (2017)
Abstracts from the 8th International Conference on cGMP Generators, Effectors and Therapeutic Implications : Bamberg, Germany. 23-25 June, 2017
18 (Suppl 1), 64
DOI 10.1186/s40360-017-0170-5, PubMed 29035170

Publications 2016

Buonacera A, Boukhris M, Tomasello SD, Campagna A, Cilia C, Tripepi G, Di Marca S, Terranova V, Pisano M, Mastrosimone G, Galassi AR, Stancanelli B, Cataliotti A, Malatino L (2016)
Impact of left ventricular remodeling and renal function on 24h-ECG recordings and cardiovascular outcome in elderly hypertensive patients
29, 71-7
DOI 10.1016/j.ejim.2016.01.001, PubMed 26781517

Publications 2015

Bellavia D, Cataliotti A, Clemenza F, Baravoglia CH, Luca A, Traina M, Gridelli B, Bertani T, Burnett JC, Scardulla C (2015)
Long-Term Structural and Functional Myocardial Adaptations in Healthy Living Kidney Donors: A Pilot Study
10 (11), e0142103
DOI 10.1371/journal.pone.0142103, PubMed 26556804

Holditch SJ, Schreiber CA, Nini R, Tonne JM, Peng KW, Geurts A, Jacob HJ, Burnett JC, Cataliotti A, Ikeda Y (2015)
B-Type Natriuretic Peptide Deletion Leads to Progressive Hypertension, Associated Organ Damage, and Reduced Survival: Novel Model for Human Hypertension
66 (1), 199-210
DOI 10.1161/HYPERTENSIONAHA.115.05610, PubMed 26063669

Røsjø H, Dahl MB, Jørgensen M, Røysland R, Brynildsen J, Cataliotti A, Christensen G, Høiseth AD, Hagve TA, Omland T (2015)
Influence of glycosylation on diagnostic and prognostic accuracy of N-terminal pro-B-type natriuretic peptide in acute dyspnea: data from the Akershus Cardiac Examination 2 Study
61 (8), 1087-97
DOI 10.1373/clinchem.2015.239673, PubMed 26056354

Publications 2014

Aspelin T, Eriksen M, Ilebekk A, Cataliotti A, Carlson CR, Lyberg T (2014)
β-blockade abolishes the augmented cardiac tPA release induced by transactivation of heterodimerised bradykinin receptor-2 and β2-adrenergic receptor in vivo
112 (5), 951-9
DOI 10.1160/TH14-01-0059, PubMed 25078038

Publications 2012

Mangiafico S, Costello-Boerrigter LC, Andersen IA, Cataliotti A, Burnett JC (2012)
Neutral endopeptidase inhibition and the natriuretic peptide system: an evolving strategy in cardiovascular therapeutics
34 (12), 886-893c
DOI 10.1093/eurheartj/ehs262, PubMed 22942338